Microscopic Polyangiitis

VF Announces 2023 V-RED Winners

It’s been a year of surprises for our Vasculitis Recognizing Excellence in Diagnosis (V-RED) award program. We have two winners who tied for first place, two winners who received honorable mentions, and this is the first year we’ve had a winner from Germany and Saskatoon, Canada. This is the 10th…...

Read more

JOHN STADLER | VF Patient Hero 2022

Microscopic Polyangiitis (MPA) • 2017 “In 2017 I was diagnosed with MPA that would change my life forever. While my life changed, I learned over time to adapt and adjust to my new reality learning how to live with and thrive with Vasculitis.”...

Read more

SANDY NYE | VF Patient Hero 2022

Microscopic Polyangiitis (MPA) • 2014 "Be positive; Advocate for your care; Connect with other Vasculitis patients; Practice Mindfulness; Laugh; Ask questions; Keep a medical journal; Remember your medication; Join and/or donate to the Vasculitis Foundation; Smile"...

Read more

KAI AUSTIN | VF Patient Hero 2022

Granulomatosis withpolyangiitis (GPA) • 2016 "Your best is yet to come."...

Read more

Amgen Successfully Completes Acquisition of ChemoCentryx

TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat…...

Read more